The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the ...
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...
Spironolactone has become a go-to treatment for stubborn hormonal acne—but is it really the “miracle” fix people claim it is? Dermatologists explain how this blood pressure medication helps treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results